New Research Study Provides Further Evidence of Strong Correlation of TriPath Imaging's ProEx C Biomarkers with Biopsy Evidence

Dow Jones

39,671.04

Get Started

Share Name	Share Symbol	Market	Type
Tripath Imaging	NASDAQ:TPTH	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%							0	-

New Research Study Provides Further Evidence of Strong Correlation of TriPath Imaging's ProEx C Biomarkers with Biopsy Evidence

07/11/2005 4:46pm

PR Newswire (US)

Tripath Imaging (NASDAQ:TPTH)
Historical Stock Chart

From May 2019 to May 2024

Click Here for more Tripath Imaging Charts.

In-house and External Retrospective Research Studies Incorporating ProEx C Biomarkers Presented at 53rd Annual Scientific Meeting of the American Society of Cytopathology BURLINGTON, N.C., Nov. 7 /PRNewswire-FirstCall/ -- TriPath Imaging, Inc. (NASDAQ:TPTH) today announced that the results of a new in-house retrospective research study demonstrated that testing of cervical cytology specimens with Research Use Only (RUO) reagents incorporating the Company's proprietary ProEx C biomarkers yielded a 93% (p